Lexeo Therapeutics, Inc. · NASDAQ:LXEO
Frazier Life Sciences Public Fund, L.P. reported a 5.70% stake in Lexeo Therapeutics, Inc. (Schedule 13G/A)
Event Jun 30, 2025 · Filed Aug 14, 2025
Frazier Life Sciences Public Fund, L.P. reported a 5.70% stake in Lexeo Therapeutics, Inc., 3,073,467 shares, as a passive investor on Jun 30, 2025. Filed Aug 14, 2025 (Schedule 13G/A).
- Stake
- 5.70%
- Shares
- 3,073,467
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 20 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Frazier Life Sciences Public Fund, L.P. | 5.70% | 3,073,467 |
| FHMLSP, L.P. | 5.70% | 3,073,467 |
| FHMLSP, L.L.C. | 5.70% | 3,073,467 |
| Frazier Life Sciences Public Overage Fund, L.P. | 1.20% | 624,804 |
| FHMLSP Overage, L.P. | 1.20% | 624,804 |
| FHMLSP Overage, L.L.C. | 1.20% | 624,804 |
| Frazier Life Sciences X, L.P. | 0.20% | 87,424 |
| FHMLS X, L.P. | 0.20% | 87,424 |
| FHMLS X, L.L.C. | 0.20% | 87,424 |
| Frazier Life Sciences XI, L.P. | 0.40% | 232,784 |
| FHMLS XI, L.P. | 0.40% | 232,784 |
| FHMLS XI, L.L.C. | 0.40% | 232,784 |
| Frazier Life Sciences XII, L.P. | 0.80% | 406,246 |
| FHMLS XII, L.P. | 0.80% | 406,246 |
| FHMLS XII, L.L.C. | 0.80% | 406,246 |
| James N. Topper | 0.20% | 87,424 |
| Patrick J. Heron | 0.20% | 87,424 |
| Albert Cha | 0% | 0 |
| James Brush | 0% | 0 |
| Daniel Estes | 0% | 0 |
Source
Related
- Lexeo Therapeutics, Inc.
- Frazier Life Sciences Public Fund, L.P.
- Lexeo Therapeutics, Inc. shareholders
- Schedule 13G/A · Frazier Life Sciences Public Fund, L.P. · Feb 13, 2026
- Schedule 13G · Frazier Life Sciences Public Fund, L.P. · Jun 4, 2025
- Schedule 13G · JPMorgan Chase & Co · Oct 13, 2026
- Form 4 · Bhalla Narinder Pal · Sep 28, 2026
- Form 4 · Otero Jose Manuel · Sep 28, 2026
- Form 4 · Townsend Richard Nolan · Sep 28, 2026
- Form 4 · Tamayo Louis Edward · Aug 19, 2026